Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

Partner news

Period

(-) 2022
2021
2019
2018
2017
2016
2014
2012
2011
2010
2009

Jan
(-) Feb
Mar
Apr
May
Jun

Locations & regions

Focus area

Clear filters

News

25 February 2022

Biocom conference charts prospects for life sciences industry amid stock market volatility

Read full story

17 February 2022

Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing

Read full story

8 February 2022

VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform

Read full story

3 February 2022

Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates

Read full story

2 February 2022

CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)

Read full story

2 February 2022

Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Read full story

Sidebar

Currently trending

Currently trending

Paige Announces Collaboration to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings
Serotiny Announces a Research Collaboration With Janssen to Optimize Designs for Chimeric Antigen Receptors Signaling Domains
Hangzhou DAC Biotechnology Announces a Collaboration and License Agreement with Janssen for the Development of Novel Antibody-Drug Conjugates
Locus Biosciences Announces $35 Million Financing
VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen
Bioasis Enters Into Research Collaboration With Janssen
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biocom conference charts prospects for life sciences industry amid stock market volatility
Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing
VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform

Trending

Trending

A JLABS Collaboration: DC4U

A JLABS Collaboration: Neurocast

Johnson & Johnson Innovation: Our Partnership Story